Enteric fever, commonly known as typhoid fever, is a systemic infection primarily caused by Salmonella Typhi or Salmonella Paratyphi. Despite advances in healthcare, it remains a significant public health issue, especially in developing countries. Early diagnosis and effective management are critical in reducing morbidity and mortality associated with the disease.
Diagnosis of enteric fever relies on clinical presentation, culture techniques, and serological tests. Clinical suspicion should be high in patients presenting with prolonged fever, abdominal pain, and constipation or diarrhea. Blood cultures remain the gold standard for diagnosis, with a sensitivity of 40-60%. However, their utility is limited by the necessity of specialized equipment and trained staff. Serological tests, such as the Widal test, offer a more accessible alternative but suffer from low specificity and sensitivity.
Recent advances have aimed at improving diagnostic accuracy and speed. Polymerase chain reaction (PCR) techniques targeting specific genes of Salmonella Typhi and Paratyphi have shown promising results. Rapid diagnostic tests (RDTs) based on the detection of specific antigens or antibodies are also being developed and evaluated.
Management of enteric fever involves both supportive care and antibiotic therapy. Fluid and electrolyte management is crucial in patients with severe disease. Antibiotic choice should be guided by local susceptibility patterns. Empiric therapy with a third-generation cephalosporin or fluoroquinolone is often initiated until culture results are available. In the case of drug-resistant strains, newer agents like azithromycin have shown efficacy.
In conclusion, enteric fever remains a significant health challenge necessitating prompt diagnosis and effective management. Advancements in diagnostic techniques and the judicious use of antibiotics are vital in reducing the disease burden. Continued research and development into improved diagnostic tools and therapeutic strategies are crucial in the fight against this enduring disease.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation